Get the ChemPriceHub app— track prices on the go. Membership syncs across app & web.
View plans
Privacy choicesWe use cookies to improve your experience
We use cookies and similar technologies to keep the site secure and understand traffic. Analytics cookies are optional and will stay off unless you choose to enable them. Read our Privacy Notice.
Always onSecurity, session continuity, and core site functionality.
OptionalAnalytics stays off until you explicitly accept or enable it.
Cookie Preferences
Manage your cookie preferences here. Essential cookies are always enabled so the site can function correctly. You can change your choice at any time via the "Cookie Settings" link in the footer. Read our Privacy Notice for full details.
Essential Cookies
Required for basic site functionality, including anti-spam protection and session management. Always active.
Analytics Cookies
Help us understand how visitors interact with the site. We use Google Analytics only when you accept analytics cookies. Disabling this will not affect essential functionality.
Feedstock diversity is a double-edged sword. It cushions supply shocks when one harvest falters, but buyers should verify the botanical origin on the certificate of analysis. Cineole from non-eucalyptus sources can carry different trace impurity profiles, which may fail pharmacopoeia monographs even when assay purity looks acceptable on paper.
The feed opportunity is real but slow to monetize. Registration, palatability trials and on-farm validation take time, and many integrators still benchmark cost per unit of gain against the antibiotics being replaced. Watch whether cineole suppliers can hold a price premium over generic eucalyptus oil once feed demand scales.